Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-23-025845

Options or other derivatives

  • Director acquired 0 shares (option exercise)
  • Director acquired 28,326 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Pershing Edward Director 2023-07-28 Option exercise · 8% Unsecured Convertible Promissory Note −0 D
Pershing Edward Director 2023-07-28 Option exercise · Series D-1 Convertible Preferred Stock +28,326 563,891 D
Loading xslF345X05/ownership.xml…